Biotest AG reported earnings results for the first half of 2021. Group recorded a revenue in the amount of EUR 257.8 million (same period of the previous year: EUR 234.8 million). On a half-year basis, sales are EUR 23.0 million or 9.8 % above the figure for the same period last year. Loss before interest and taxes (LBIT) amounted to EUR 8.5 million in the first six months of financial year 2021 (same period of the previous year: EUR 0.7 million).